Li, Yongqi
Zhao, Dawei
Zhang, Wenqiu
Yang, Miaomiao
Wu, Zhihui
Shi, Weiguo
Lan, Shijie
Guo, Zhen
Yu, Hong
Funding for this research was provided by:
Natural Science Foundation of Jilin Province (20200201479JC)
Article History
Received: 23 June 2022
Accepted: 14 May 2023
First Online: 29 June 2023
Declarations
:
: The study was approved by the Institutional Review Board (IRB) of The First Hospital of Jilin University. All subjects were provided a written informed consent.
: I give my consent for the article to publish in Journal of translational medicine, section of tumor chemotherapy.
: The authors declare that they have no competing of interest.